Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes. 1980

T Abel, and B S Andrews, and P H Cunningham, and C M Brunner, and J S Davis, and D A Horwitz

A study of five patients with severe rheumatoid vasculitis treated with cyclophosphamide was undertaken to determine whether immune complexes were present in serum and if their levels correlated with disease activity and response to treatment. Circulating immune complexes were measured by various techniques including the Clq binding and Raji cell radioimmunoassays and determination of the presence of cryoglobulins. Elevated levels of circulating immune complexes, hypocomplementemia, and high titer rheumatoid factor were present during active vasculitis. Clinical and serologic remissions were induced in all patients on cyclophosphamide. In two patients in remission, a rise in rheumatoid factor titer and immune complex levels was associated with an exacerbation of vasculitis and resolved on increased cyclophosphamide dosage. The Clq binding assay and rheumatoid factor titer correlated best with clinical activity. Thus, circulating immune complexes appear to be involved in the immunopathogenesis of rheumatoid vasculitis, which can be successfully treated with cyclophosphamide.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012217 Rheumatoid Factor Autoantibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS. Factor, Rheumatoid
D014657 Vasculitis Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body. Angiitis,Angiitides,Vasculitides

Related Publications

T Abel, and B S Andrews, and P H Cunningham, and C M Brunner, and J S Davis, and D A Horwitz
December 1979, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
T Abel, and B S Andrews, and P H Cunningham, and C M Brunner, and J S Davis, and D A Horwitz
April 1985, Revue du rhumatisme et des maladies osteo-articulaires,
T Abel, and B S Andrews, and P H Cunningham, and C M Brunner, and J S Davis, and D A Horwitz
July 1977, Clinical and experimental immunology,
T Abel, and B S Andrews, and P H Cunningham, and C M Brunner, and J S Davis, and D A Horwitz
January 1985, Revmatologiia (Moscow, Russia),
T Abel, and B S Andrews, and P H Cunningham, and C M Brunner, and J S Davis, and D A Horwitz
December 1979, The Journal of clinical investigation,
T Abel, and B S Andrews, and P H Cunningham, and C M Brunner, and J S Davis, and D A Horwitz
March 1980, The American journal of medicine,
T Abel, and B S Andrews, and P H Cunningham, and C M Brunner, and J S Davis, and D A Horwitz
January 1990, Terapevticheskii arkhiv,
T Abel, and B S Andrews, and P H Cunningham, and C M Brunner, and J S Davis, and D A Horwitz
January 1986, The Quarterly journal of medicine,
T Abel, and B S Andrews, and P H Cunningham, and C M Brunner, and J S Davis, and D A Horwitz
February 1985, The Journal of rheumatology,
T Abel, and B S Andrews, and P H Cunningham, and C M Brunner, and J S Davis, and D A Horwitz
October 1975, Annals of the rheumatic diseases,
Copied contents to your clipboard!